Private equity firms Ardian, Mubadala Capital, GIC and APG Group agreed to acquire a minority stake in Labosud, a French medical and laboratory diagnostic company, from Inovie for $1.9bn. "To be able to keep up with future challenges in clinical pathology, notably in terms of development, diversification and innovation, we had to evolve our model and find new resources whilst staying close to our roots. We are very pleased to have built a project for the future with Ardian, which stays true to our core values relating to better supporting our patients in the course of their care by bringing together the best practitioners in clinical pathology. This is thanks to the dedication and competence of our teams in their daily work," Georges Ruiz, Inovie President.